Workshop Report and Follow-Up—AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples—Implications of Crystal City Recommendations

Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, Shah VP, Skelly JP, Swann PG, Weiner R. Workshop/Conference Report—Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays. AAPS Journal. 2007;9(1):E30–42.

Fast D, Kavetskaia O, Macrae P, Steenwyk R. A Pfizer process for demonstrating assay reproducibility in GLP studies. Boston MA: Applied Pharmaceutical Analysis 2007.

Bansal S. Repeat bioanalysis selection and reporting. Arlington, VA: AAPS Workshop: Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays;2006.

Rocci ML Jr, Devanarayan V, Haughey DB, Jardieu P. Confirmatory reanalysis of incurred bioanalytical samples. AAPS Journal. 2007;9(3):E336–43.

Jemal M, Ouyang Z, Powell ML. A strategy for a post-method-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples. Rapid Commun Mass Spectrom. 2002;16:1538–47.

Brockman AH, Hatsis P, Paton M, Wu J-T. Impact of differential recovery in bioanalysis: the example of bortezomib in whole blood. Anal Chem. 2007;79:1599–603.

Larsson M, Han F. Determination of rifalazil in dog plasma by liquid–liquid extraction and LC-MS/MS: quality assessment by incurred sample analysis. J Pharm Biomed Anal. 2007;45:616–24.